Universitätsklinikum Schleswig-Holstein (UKSH)


Lübeck / Kiel, Germany

Publications in cooperation with FAU scientists

Go to first page Go to previous page 1 of 13 Go to next page Go to last page
Moosig, F., Schmalzing, M., Aries, P.M., Henes, J., Lamprecht, P., Rech, J., & Witte, T. (2019). Actual Treatment Options for Giant Cell Arteritis. Deutsche Medizinische Wochenschrift, 144(9), 595-600. https://dx.doi.org/10.1055/a-0832-3563
Heinzerling, L., Ascierto, P.A., Dummer, R., Gogas, H., Grob, J.-J., Lebbe, C.,... Hauschild, A. (2019). Adverse events 2.0-Let us get SERIOs New reporting for adverse event outcomes needed in the era of immunooncology. European journal of cancer, 112, 29-31. https://dx.doi.org/10.1016/j.ejca.2019.01.015
Ditsch, N., Untch, M., Thill, M., Müller, V., Janni, W., Albert, U.S.,... Wöckel, A. (2019). AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019. Breast Care. https://dx.doi.org/10.1159/000501000
Thill, M., Jackisch, C., Janni, W., Müller, V., Albert, U.S., Bauerfeind, I.,... Ditsch, N. (2019). AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019. Breast Care. https://dx.doi.org/10.1159/000500999
Kolios, A.G.A., Hueber, A., Michetti, P., Mrowietz, U., Mustak-Blagusz, M., Sator, P.-G.,... Schiefke, I. (2019). ALIGNed on adherence: subanalysis of adherence in immune-mediated inflammatory diseases in the DACH region of the global ALIGN study. Journal of the European Academy of Dermatology and Venereology, 33(1), 234-241. https://dx.doi.org/10.1111/jdv.15179
Reiff, T., Eckstein, H.H., Mansmann, U., Jansen, O., Fraedrich, G., Mudra, H.,... Ringleb, P.A. (2019). Angioplasty in asymptomatic carotid artery stenosis vs. endarterectomy compared to best medical treatment: One-year interim results of SPACE-2. International Journal of Stroke. https://dx.doi.org/10.1177/1747493019833017
Mayer, I.A., Prat, A., Egle, D., Blau, S., Alejandro Perez Fidalgo, J., Gnant, M.,... Arteaga, C.L. (2019). A phase II randomized study of neoadjuvant letrozole plus alpelisib for hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (NeO-ORB). Clinical Cancer Research, 25(10), 2975-2987. https://dx.doi.org/10.1158/1078-0432.CCR-18-3160
Wunderle, M., Pretscher, J., Brucker, S.Y., Volz, B., Hartmann, A., Fiessler, C.,... Rauh, C. (2019). Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer. Breast Cancer Research and Treatment, 174(2), 453-461. https://dx.doi.org/10.1007/s10549-018-05115-6
Kaehler, K., Bohne, A.S., Gutzmer, R., Satzger, I., Meier, F., Reinhardt, L.,... Ugurel, S. (2019). Association of an initial Exanthem with Vemurafenib and Cobimetinib for a better Therapeutic Success in metastatic Melanoma Patients. In JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (pp. 54-55). HOBOKEN: WILEY.
Straka, C., Knop, S., Vogel, M., Müller, J., Kropff, M., Metzner, B.,... Einsele, H. (2019). Bortezomib consolidation following autologous transplant in younger and older patients with newly diagnosed multiple myeloma in two phase III trials. European Journal of Haematology. https://dx.doi.org/10.1111/ejh.13281
Kuta, P., Melling, N., Zimmermann, R., Achenbach, S., Eckstein, R., & Strobel, J. (2019). Clotting factor activity in fresh frozen plasma after thawing with a new radio wave thawing device. Transfusion, 59(5), 1857-1861. https://dx.doi.org/10.1111/trf.15246
Konrad, E., Nardini, N., Caliebe, A., Nagel, I., Young, D., Horvath, G.,... Zweier, C. (2019). CTCF variants in 39 individuals with a variable neurodevelopmental disorder broaden the mutational and clinical spectrum. Genetics in Medicine. https://dx.doi.org/10.1038/s41436-019-0585-z
Scheer, M., Vokuhl, C., Blank, B., Hallmen, E., Von Kalle, T., Muenter, M.,... Koscielniak, E. (2019). Desmoplastic small round cell tumors: Multimodality treatment and new risk factors. Cancer Medicine, 8(2), 527-542. https://dx.doi.org/10.1002/cam4.1940
Laakmann, E., Witzel, I., Fasching, P., Rezai, M., Schem, C., Solbach, C.,... Loibl, S. (2019). Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto. Breast Cancer Research, 21(1). https://dx.doi.org/10.1186/s13058-019-1144-x
Tesch, H., Stoetzer, O., Decker, T., Kurbacher, C.M., Marme, F., Schneeweiss, A.,... Taran, F.-A. (2019). Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial. International Journal of Cancer, 144(4), 877-885. https://dx.doi.org/10.1002/ijc.31738
Fuhrer, H., Schoenenberger, S., Niesen, W.-D., Seide, S., Meyne, J., Gerner, S.,... Neugebauer, H. (2019). Endovascular stroke treatment’s impact on malignant type of edema (ESTIMATE). Journal of Neurology, 266(1), 223-231. https://dx.doi.org/10.1007/s00415-018-9127-x
Oosterhaven, J.A.F., Uter, W., Aberer, W., Armario-Hita, J.C., Ballmer-Weber, B.K., Bauer, A.,... Grabbe, J. (2019). European Surveillance System on Contact Allergies (ESSCA): Contact allergies in relation to body sites in patients with allergic contact dermatitis. Contact Dermatitis, 80(5), 263-272. https://dx.doi.org/10.1111/cod.13192
Janning, M., Müller, V., Vettorazzi, E., Cubas-Cordova, M., Gensch, V., Ben-Batalla, I.,... Loges, S. (2019). Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial. International Journal of Cancer. https://dx.doi.org/10.1002/ijc.32163
Gómez Ruiz, M., Alfieri, S., Becker, T., Bergmann, M., Boggi, U., Collins, J.,... Vaz, C. (2019). Expert consensus on a train-the-trainer curriculum for robotic colorectal surgery. Colorectal Disease. https://dx.doi.org/10.1111/codi.14637
Reinartz, G., Pyra, R.P., Lenz, G., Liersch, R., Stueben, G., Micke, O.,... Eich, H.T. (2019). Favorable radiation field decrease in gastric marginal zone lymphoma Experience of the German Study Group on Gastrointestinal Lymphoma (DSGL). Strahlentherapie und Onkologie, 195(6), 544-557. https://dx.doi.org/10.1007/s00066-019-01446-5

Last updated on 2016-11-05 at 13:31

Share link